Subtopic Deep Dive

Androgen Receptor Mutations
Research Guide

What is Androgen Receptor Mutations?

Androgen receptor mutations are genetic variants in the AR gene that impair androgen signaling, causing androgen insensitivity syndrome (AIS) and related disorders of sex development.

Over 1,000 AR mutations are cataloged, leading to complete, partial, or mild AIS phenotypes (Gottlieb et al., 2012). Research spans historical clinical descriptions to molecular assays of receptor function (Quigley et al., 1995). Population studies reveal prevalence and genotype-phenotype correlations (Eggers et al., 2016).

Curated Papers

Key Challenges

Why It Matters

AR mutation analysis enables precise diagnosis of AIS, guiding management of disorders of sex development and reducing germ cell tumor risks (Cools et al., 2006; Hughes, 2005). Functional studies inform therapies for AIS and prostate cancer by targeting mutant AR structures (Tan et al., 2014; Brinkmann, 2001). Databases like Gottlieb et al. (2012) support genetic counseling and drug discovery for AR-related diseases.

Key Research Challenges

Genotype-Phenotype Correlation

Varied clinical outcomes from similar AR mutations challenge predictions due to assay limitations (Quigley et al., 1995). Functional studies show incomplete correlations influenced by modifiers (Brinkmann, 2001). Gottlieb et al. (2012) database highlights unexplained mild AIS cases.

Mutation Functional Assays

In vitro assays often fail to replicate in vivo androgen insensitivity (Tan et al., 2014). Splicing variants complicate standard sequencing (Dehm and Tindall, 2011). Large cohort sequencing reveals novel variants needing validation (Eggers et al., 2016).

Therapeutic Targeting

Mutant AR structures resist standard androgen blockers in AIS and cancer (Tan et al., 2014). Drug discovery requires precise structure-function data (Brinkmann, 2001). Intersex management lacks mutation-specific guidelines (Hughes, 2005).

Essential Papers

Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*

Charmian A. Quigley, Alessandra De Bellis, Keith B. Marschke et al. · 1995 · Endocrine Reviews · 1.5K citations

IN 1953 lohn Morris, an obstetrician at Yale University, reported a series of 82 individuals (80 cases collated from the literature and two cases of his own) who had a female phenotype despite the ...

Consensus statement on management of intersex disorders

Ieuan A. Hughes · 2005 · Archives of Disease in Childhood · 1.4K citations

Androgen receptor: structure, role in prostate cancer and drug discovery

M-H. Tan, Jun Li, H. Eric Xu et al. · 2014 · Acta Pharmacologica Sinica · 875 citations

Androgens and androgen receptors (AR) play a pivotal role in expression of the male phenotype. Several diseases, such as androgen insensitivity syndrome (AIS) and prostate cancer, are associated wi...

Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers

Martine Cools, Stenvert L. S. Drop, Katja P. Wolffenbuttel et al. · 2006 · Endocrine Reviews · 543 citations

The risk for the development of germ cell tumors is an important factor to deal with in the management of patients with disorders of sex development (DSD). However, this risk is often hard to predi...

The androgen receptor gene mutations database: 2012 update

Bruce Gottlieb, Lenore K. Beitel, Abbesha Nadarajah et al. · 2012 · Human Mutation · 499 citations

The current version of the androgen receptor gene (AR) mutations database is described. A major change to the database is that the nomenclature and numbering scheme now conforms to all Human Genome...

Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects

Richard M. Sharpe, Niels E. Skakkebæk · 2008 · Fertility and Sterility · 431 citations

Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome

Karine Morcel, Laure Camborieux, Daniel Guerrier et al. · 2007 · Orphanet Journal of Rare Diseases · 415 citations

Reading Guide

Foundational Papers

Start with Quigley et al. (1995) for clinical-molecular history of AIS; Hughes (2005) for intersex management consensus; Gottlieb et al. (2012) for comprehensive mutation database.

Recent Advances

Eggers et al. (2016) for large-cohort sequencing insights; Tan et al. (2014) for AR structure in disease and drug design.

Core Methods

AR sequencing with HGVS nomenclature (Gottlieb et al., 2012); functional transactivation assays (Brinkmann, 2001); targeted gene panels in DSD cohorts (Eggers et al., 2016).

How PapersFlow Helps You Research Androgen Receptor Mutations

Discover & Search

Research Agent uses searchPapers and citationGraph to map AR mutation literature from Quigley et al. (1995, 1457 citations) to Gottlieb et al. (2012) database updates, revealing 1,000+ variants. exaSearch uncovers cohort studies like Eggers et al. (2016); findSimilarPapers links AIS to germ cell risks in Cools et al. (2006).

Analyze & Verify

Analysis Agent employs readPaperContent on Gottlieb et al. (2012) to extract mutation counts and HGVS nomenclature, then verifyResponse with CoVe checks claims against Quigley et al. (1995). runPythonAnalysis parses variant frequencies from Eggers et al. (2016) CSV data using pandas for statistical prevalence; GRADE grading scores evidence strength for AIS diagnosis.

Synthesize & Write

Synthesis Agent detects gaps in genotype-phenotype links between Brinkmann (2001) and Tan et al. (2014), flagging contradictions in splicing effects (Dehm and Tindall, 2011). Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Hughes (2005), with latexCompile for publication-ready output and exportMermaid for AR signaling diagrams.

Use Cases

"Analyze mutation frequencies in AIS cohorts from recent sequencing studies"

Research Agent → searchPapers('AIS AR mutations sequencing') → Analysis Agent → runPythonAnalysis(pandas on Eggers et al. 2016 data) → outputs prevalence stats CSV with p-values.

"Generate LaTeX review of AR structure mutations and AIS phenotypes"

Synthesis Agent → gap detection(Quigley 1995, Tan 2014) → Writing Agent → latexEditText + latexSyncCitations(15 papers) + latexCompile → outputs compiled PDF with AR domain figure.

"Find code for AR mutation functional assay simulations"

Research Agent → paperExtractUrls(Brinkmann 2001) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs Python scripts for receptor binding models.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers(AR mutations AIS) → citationGraph → readPaperContent(20 top papers like Gottlieb 2012) → GRADE report on 50+ papers. DeepScan analyzes Eggers et al. (2016) cohort: 7-step verification with CoVe checkpoints for variant novelty. Theorizer generates hypotheses on AR splicing modifiers from Dehm and Tindall (2011) + Tan et al. (2014).

Try Doxa for Androgen Receptor Mutations Research

Frequently Asked Questions

What defines androgen receptor mutations?

AR gene variants disrupting ligand binding, DNA binding, or transactivation cause AIS phenotypes from complete female to mild undervirilization (Quigley et al., 1995).

What are key methods for studying AR mutations?

Sequencing identifies variants per HGVS norms; functional assays test ligand binding and transcription; databases like Gottlieb et al. (2012) catalog >1,000 entries (Eggers et al., 2016).

What are seminal papers on AR mutations?

Quigley et al. (1995, 1457 citations) provides historical-molecular overview; Gottlieb et al. (2012, 499 citations) updates AR mutations database; Tan et al. (2014, 875 citations) details structure-function.

What open problems exist in AR mutation research?

Unresolved genotype-phenotype discrepancies; validation of novel variants from cohorts; therapies targeting mutant AR in AIS and cancer (Brinkmann, 2001; Tan et al., 2014).